CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Nastroon Feb 05, 2019 2:53pm

83 Views

Post# 29322052

RE:RE:RE:RE:RE:RE:RE:Next up..FDA

This is very true and a very good point. However, I doubt any of the clinicians involved in the US trials will be permitted to give an opinion on the CSS until FDA has been cleared, so we might be waiting a while for that. However, once that milestone has been reached, with luck we should see some pretty powerful endorsements from some top rated institutions. After all the last published results gave the device an accuracy rate of 96% which is pretty darned good.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week